BGN and gastric cancer: The HRs were 1.44 (95% CI 1.02-2.06, p = 0.038) and 2.16 (95% CI 1.22-3.87, p = 0.007) for high BGN expression in stages I-III (n = 365) and stage IV gastric cancer patients, respectively (Figures 1(c) and 1(d)).